Giant cell tumor of bone: The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis

Pathobiology

Volumn 70, Issue 6, 2002, Pages 333-342

  Robinson, Dror ^a,b   Segal, Michael ^a   Nevo, Zvi ^b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

CD34+; Collagen type IIa; Fibroblast growth factor 3 receptor; Giant cell tumor; Mesenchymal cells; U 937 cells

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR RECEPTOR 3; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PAPAIN; RETINOIC ACID;

ANTIGEN PRESENTATION; ARTICLE; BONE; BONE TUMOR; CARTILAGE; CELL ACTIVATION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRAIN U937; CELL SUBPOPULATION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ACTIVITY; EVALUATION; EXPLANT; GIANT CELL TUMOR; HISTIOCYTE; HISTIOCYTIC LYMPHOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MEASUREMENT; MESENCHYME; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STAINING; STROMA; TUMOR CELL; TUMOR CELL CULTURE;

ALKALINE PHOSPHATASE; ANTIGENS, CD34; BIOLOGICAL MARKERS; BONE NEOPLASMS; CARRIER PROTEINS; CELL DIVISION; COLLAGEN TYPE II; CULTURE MEDIA, CONDITIONED; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GIANT CELL TUMOR OF BONE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MEMBRANE GLYCOPROTEINS; MESENCHYMAL STEM CELLS; OSTEOCALCIN; PROTO-ONCOGENE PROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TRETINOIN; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0037634712     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071273     Document Type: Article

References (29)

1. Brecher ME, Franklin WA, Simon MA: Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone. Am J Pathol 1986;125:252-257.
2. Bumester GR, Winchester RJ, Dimitriu-Bona A, Klein M, Steiner G, Sissons HA: Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens. J Clin Invest 1983;71:1633-1648.
3. Goldring SR, Schiller AL, Mankin HJ, Dayer JM, Krane SM: Characterization of cells from human giant cell tumors of bone. Clin Orthop 1986;(204):59-75.
4. Aqel NM, Pringle JA, Horton MA: Cellular heterogeneity in giant cell tumour of bone (osteoclastoma): An immunohistological study of 16 cases. Histopathology 1988;13:675-685.
5. Goldberg D, Polly P, Eisman JA, Morrison NA: Identification of an osteocalcin gene, promoter sequence that binds AP1. J Cell Biochem 1996;60:447-457.
6. Hasegawa T, Hirose T, Seki K, Sano T, Hizawa K: Transforming growth factor alpha and CD68 immunoreactivity in giant cell tumours of bone: A study on the nature of stromal and giant cells, and their interrelations. J Pathal 1993;170:305-310.
7. Robinson D, Hasharoni A, Cohen N, Yayon A, Moskowitz RM, Nevo Z: Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cells. Clin Orthop 1999;S163-S175.
8. Oganesian A, Zhu Y, Sandell LJ: Localization of type IIA procollagen during chondrogenesis. Ann NY Acad Sci 1996;785:311-313.
9. Sundstrom C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976;17:565-577.
10. Hsu SM, Hsu PL: Phenotypes and phorbol ester-induced differentiation of human histiocytic lymphoma cell lines (U-937 and SU-DHL-1) and Reed-Sternberg cells. Am J Pathol 1986;122:223-230.
11. Robinson D, Hasharoni A, Halperin N, Yayon A, Nevo Z: Mesenchymal cells and growth factors in bunions. Foot Ankle Int 1999;20:727-732.
12. Zhu Y, Oganesian A, Keene DR, Sandell LJ: Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol 1999;144:1069-1080.
13. Robinson D, Lewis MM, Nevo Z, Kenan S, Einhorn TA: The radiographic stage of giant cell tumor related to stromal cells' proliferation. Tissue cultures in 13 cases. Acta Orthop Scand 1997;68:294-297.
14. Lowry OH: Micromethods for the assay of enzyme. Methods Enzymol 1955;4:371-372.
15. Majeska RJ, Rodan GA: The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 1982;257:3362-3365.
16. Grigoriadis AE, Heersche JN, Aubin JE: Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone. J Cell Biol 1988;106:2139-2151.
17. Barroga E, Kadosawa T, Okumura M, Fujinaga T: Induction of functional differentiation and growth inhibition in vitro of canine osteosarcoma by 22-oxacalcitriol, calcitriol and all-trans-retinoic acid. Zentralbl Veterinärmed A 1999;46:573-579.
18. Bab I, Gazit D, Chorev M, Muhlrad A, Shteyer A, Greenberg Z, Namdar M, Kahn A: Histone H4-related osteogenic growth peptide (OGP): A novel circulating stimulator of osteoblastic activity. Embo J 1992;11:1867-1873.
19. Paniccia R, Colucci S, Grano M, Serra M, Zallone AZ, Teti A: Immediate cell signal by bone-related peptides in human osteoclast-like cells. Am J Physiol 1993;265:C1289-C1297.
20. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ, et al: Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
21. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
22. Butnariu-Ephrat M, Robinson D, Mendes DG, Halperin N, Nevo Z: Resurfacing of goat articular cartilage by chondrocytes derived from bone marrow. Clin Orthop 1996;(303):234-243.
23. Huang L, Xu J, Wood DJ, Zheng MH: Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-κB in giant cell tumor of bone: Possible involvement in tumor cell-induced osteoclast-like cell formation. Am J Pathol 2000;156:761-767.
24. Chikkappa G, Wang GJ, Santella D, Pasquale D: Granulocyte colony-stimulating factor (G-CSF) induces synthesis of alkaline phosphatase in neutrophilic granulocytes of chronic myelogenous leukemia patients. Leuk Res 1988:12:491-498.
25. Reddy SV, Roodman GD: Control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 1998;8:1-17.
26. Grano M, Colucci S, Zigrino P, Serra M, Scotlandi K, Tet A, Zambonin Zallone A: Integrin expression and adhesion property of osteoclast-like cells from giant cell tumours of bone. Boll Soc Ital Biol Sper 1992;68:255-258.
27. Bogumil GP, Schwamm HA: Orthopaedic Pathology. Philadelphia, Saunders, 1984.
28. De Nayer PP, Delloye C, Malghem J: Bone injury and late giant cell tumor occurrence: A possible relation. A case report. Orthopedics 1987;10:1279-1283.
29. Robinson D, Bab I, Nevo Z: Osteogenic growth peptide regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells. J Bone Miner Res 1995;10:690-696.